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Abstract: The objective of our study was to  evaluate whether feeding pseudopurpurin 
affects bone mineral density and bone geometry architecture in rats. Pseudopurpurin was 
extracted,  analyzed  and  purified  using  an  HLPC-ESI-MS.  Rats  were  given  0%  and   
0.5% pseudopurpurin powder in their diet. Femurs of rats were examined at 0.5, 1 and   
2 months after pseudopurpurin feeding. Compared with rats in the group 0%, the bone 
mineral density, and the calcium, magnesium, zinc and manganese concentrations in the 
rats  femur  in  the  group  0.5%  increased  significantly  at  1  month  and  2  months  after 
pseudopurpurin feeding. Analytical results of micro-computed tomography showed that the 
group 0.5% displayed an increase in the trabecular volume fraction, trabecular thickness 
and trabecular number of the distal femur at 1 and 2 months after pseudopurpurin feeding, 
and the mean thickness, inner perimeter, outer perimeter, and area of the femur diaphysis 
were significantly increased at 2 months after pseudopurpurin feeding compared with the 
group 0%. In parallel, the trabecular separation and structure model index of the distal 
femur  were  decreased,  compared  with  the  group  0%  at  1  and  2  months  after 
pseudopurpurin feeding. In the 0.5% and 0% groups, there was no damage to kidney and 
liver by histopathology analysis. The long-term feeding of pseudopurpurin is safe for rats. 
The feeding of 0.5% pseudopurpurin which has specific chemical affinities for calcium for 
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bone improvement and level of bone mineral density, enhances the geometry architecture 
compared with the 0% group. 
Keywords:  pseudopurpurin;  bone  mineral  density;  bone  mineral  elements;  bone   
geometry architecture 
 
1. Introduction 
Madder dyes impart a rich scarlet color to cloth and have been used since the third millennium BC. 
The specific vital  staining of developing bone  by feeding the dyestuff madder has  been common 
knowledge for hundreds of years [1–7]. Anthraquinones, present in madder roots (roots and rootstocks 
of Rubia tinctorum L.), have proved to exert different biological activities [8], such as anti-oxidant, 
anti-microbial, anti-fungal, cytotoxic, larvicidal and anti-viral activities [9]. Under normal conditions 
of madder feeding, the coloration is due to the staining of bone salts by the active components of 
madder: alizarin, purpurin and pseudopurpurin—pseudopurpurin being the most important—with these 
dyestuffs become effective when combined with calcium [10]. However, reports on the influence of 
alizarin on bone growth are confusing. From the available literature, it is known that alizarin does not 
cause retardation of growth of dentine and bone in the rat [11], and there is a temporary retardation or 
even a cessation in growth of the bones of the rabbit [12]. Pseudopurpurin resembles alizarin because 
it forms a colored metal salt that is highly insoluble in water [13], yet, as a material for vital staining of 
the  bones  in  animals,  pseudopurpurin  has  rarely  been  used.  Richter  found  that  madder  contained 
considerable quantities of pseudopurpurin, and considered that it was responsible for the vital staining 
of the bones of animals fed on madder, and was completely non-toxic to animals [14]. However, up to 
now, no experimental study has been carried out on pseudopurpurin’s use in bone mineralization. This 
therefore needs to be subjected to an in-depth study. With this in mind, we extracted pseudopurpurin 
from  madder,  then  evaluated  whether  it  affected  bone  mineral  elements  and  bone  geometry 
architecture in rats during the bone growth process, with the aim of providing further new insights into 
the effect of pseudopurpurin on bone mineralization in humans and mammals. 
2. Results and Discussion 
2.1. ESI-MS Analyses 
Because  samples  of  these  carboxylated  anthraquinones  were  not  commercially  available, 
confirmation of their identity was achieved by analysis of madder root powder with extraction using 
the described method. Identification of pseudopurpurin in this extract confirmed that the extraction 
conditions  were  non-degradative  and  suitable  for  this  kind  of  fragile  anthraquinone  colorant.  The 
colorant  was  also  observed  by  monitoring  the  deprotonated  molecule  [M–H]
−,  m/z  299.8  and  the 
[M–H–CO2]
− fragment ion at m/z 255.2 (Figure 1). The high precision of the mass measurements of 
these ions, together in comparison with the MS and UV-visible spectra described by Derksen et al. [4] 
and  the  UV-visible  spectra  described  by  Schweppe  [15],  allowed  us  to  propose  the  structure   
of pseudopurpurin.   Int. J. Mol. Sci. 2012, 13 
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Figure 1. Negative-ion mass spectra of pseudopurpurin obtained by LC-ESI-MS analysis 
of an extract of madder powder. 
 
2.2. Body Weight and Femur Length in Rats 
There were no significant differences in body weight and femur length in the 0% and 0.5% groups 
from 0.5 to 2 months after pseudopurpurin feeding (P > 0.05), however, the body weight and femur 
length in the 0.5% group rats were higher than in the 0% groups rats (Table 1). 
Table 1. Body weight and femur length of rats at 0.5, 1 and 2 months after pseudopurpurin feeding. 
    Body weight (g)  Femur length (cm) 
0.5% group 
0.5 month  24.5 ±  5.66  0.81 ±  0.057 
1 month  57.3 ±  9.37  1.78 ±  0.72 
2 months  123.6 ±  22.2  2.12 ±  0.92 
0% group 
0.5 month  23.8 ±  6.01  0.79 ±  0.034 
1 month  54.6 ±  11.57  1.55 ±  0.83 
2 months  116 ±  21.5  1.94 ±  0.94 
2.3. Bone Mineral Composition and Bone Mineral Density 
At 0.5 month after pseudopurpurin feeding, calcium (Ca), magnesium (Mg), zinc (Zn), manganese 
(Mn), and iron (Fe) levels as well as bone mineral density (BMD) in the rats femur in the group 0.5% 
were similar to those in the group 0% (P > 0.05). At 1 month and 2 months after pseudopurpurin 
feeding,  calcium  (Ca),  magnesium  (Mg),  zinc  (Zn),  and  manganese  (Mn)  levels  as  well  as  bone 
mineral density (BMD) in the rats femur in the group 0.5% were significantly increased compared with 
those in the group 0% (P < 0.05). Iron (Fe) levels in the femur were not significantly different among 
the groups (P > 0.05) (Figure 2). Int. J. Mol. Sci. 2012, 13 
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Figure 2. The level of bone mineral composition and bone mineral density in the rat femur 
in the groups 0% and 0.5% at 0.5, 1 and 2 months after pseudopurpurin feeding. Data are 
expressed as the means ±  SD; * P < 0.05 versus the group 0%. 
 
2.4. Histopathology of Internal Organs   
In the present study, no pathological changes were observed in the various organs of rats including 
heart, liver, spleen, lung, kidney, pancreas, stomach and small intestine in the groups 0% and 0.5%   
at 2 months after pseudopurpurin feeding (result of kidney and liver are shown in Figure 3, other data 
were not included).   
Figure 3. Liver sections of the group 0.5% (a) and the group 0% (b) and kidney sections of 
the group 0.5% (c) and the group 0% (d) are shown (hematoxylin and eosin (stain), 100× ). 
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2.5. Biochemical Evaluations 
Biochemical evaluations showed the levels of liver duty enzyme and kidney duty enzyme in the 
blood plasma of rats in the 0% and 0.5% groups at 2 months after pseudopurpurin feeding. The levels 
of AST, ALT, BUN and CRE in blood plasma showed no significant differences among the 0% and 
0.5% groups at 2 months after pseudopurpurin feeding (Table 2).   
Table 2. Comparison of the biochemical levels in blood plasma of rats in 0.5% and 0% 
groups at 2 months after pseudopurpurin feeding. Data are expressed as the means ±  SD;   
 
 
AST 
(U/L) 
ALT 
(U/L) 
BUN 
(mmol/L) 
CRE 
(umol/L) 
0.5% group  82.40 ±  5.47  31.24 ±  3.17  11.52 ±  1.44  22.38 ±  1.44 
0% group  83.24 ±  5.99  31.45 ±  2.66  10.79 ±  1.24  21.02 ±  1.54 
2.6. Femur Micro-CT   
The 3-D reconstruction of the bone structures and the quantification of trabecular and cortical bone 
changes in the femur by micro-CT are shown in Figure 4.   
Figure 4. (a) Three-dimensional images of the distal femur in rats in the 0.5% group at 0.5, 
1 and 2 months after pseudopurpurin feeding. (b) Three-dimensional images of the distal 
femur  in  rats  in  the  0%  group  at  0.5,  1  and  2  months  after  pseudopurpurin  feeding.   
(c) Three-dimensional images of the femur diaphysis in rats in the 0.5% group at 0.5, 1 and   
2  months  after  pseudopurpurin  feeding.  (d)  Three-dimensional  images  of  the  femur 
diaphysis in rats in the 0% group at 0.5, 1 and 2 months after pseudopurpurin feeding. 
 
The mean thickness, inner perimeter, outer perimeter, marrow area, cortical area and total area of 
the femur diaphysis, together with the bone volume fraction (BV/TV), trabecular thickness (Tb.Th), 
trabecular number (Tb.N), trabecular separation (Tb.Sp) and structure model index (SMI) of the distal Int. J. Mol. Sci. 2012, 13 
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femur in the 0.5% groups were not significantly different compared to the 0% group at 0.5 months 
after pseudopurpurin feeding (all P > 0.05).   
One month after pseudopurpurin feeding, BV/TV, Tb.Th and Tb.N were significantly increased and 
Tb.Sp and SMI were significantly decreased in the distal femur in the 0.5% groups compared with 
those in the 0% group (all P < 0.05). There were no differences in any of the parameters of the femur 
diaphysis among rats in the 0% and 0.5% groups (all P > 0.05).   
Two months after pseudopurpurin feeding, the mean thickness, outer perimeter, cortical area, total 
area, inner perimeter and marrow area in the femur diaphysis, as well as BV/TV, Tb.Th and Tb.N in 
the distal femur in the 0.5% groups were significantly increased and Tb.Sp and SMI were significantly 
decreased compared with the 0% group (all P < 0.05) (Tables 3 and 4).   
Table 3. 3-D micro-structural properties of the distal femur in rats in groups 0.5% and 0%. 
Data are expressed as the means ±  SD; * P < 0.05 versus 0% group rats. Bone volume 
fraction  (BV/TV),  trabecular  thickness  (Tb.Th),  trabecular  number  (Tb.N),  trabecular 
separation (Tb.Sp) and structure model index (SMI). 
    BV/TV (%)  Tb.Th (mm) 
Tb.N 
(/mm) 
Tb.Sp (um)  SMI 
0% group rats 
0.5 month 
2.32 ±  0. 3  0.051 ±  0.009  2.76 ±  0.58  0.365 ±  0.03  2.22 ±  0.3 
0.5% group rats  2.38 ±  0.5  0.054 ±  0.01  2.77 ±  0.69  0.370 ±  0.037  2.20 ±  0.4 
0% group rats 
1 month 
3.16 ±  0.04  0.08 ±  0.007  3.16 ±  1.11  0.295 ±  0.013  1.92 ±  0.03 
0.5% group rats  3.82 ±  0.03 *  0.13 ±  0.007 *  4.01 ±  1.07 *  0.216 ±  0.014 *  1.30 ±  0.02 * 
0% group rats 
2 months 
5.61 ±  0.08  0.15 ±  0.05  3.99 ±  1.0  0.218 ±  0.003  1.41 ±  0.011 
0.5% group rats  6.75 ±  0.08 *  0.23 ±  0.04 *  5.16 ±  1.3 *  0.167 ±  0.005 *  0.86 ±  0.01 * 
Table 4. 3-D micro-structural properties of the mid-femur diaphysis in rats in groups 0.5% 
and 0%. Data are expressed as the means ±  SD; * P < 0.05 versus 0% group rats. 
   
Mean 
Thickness 
(mm) 
Inner 
Perimeter 
(mm) 
Outer 
Perimeter 
(mm) 
Marrow 
Area (mm
2) 
Cortical 
Area (mm
2) 
Total Area 
(mm
2) 
0% group rats  0.5 
month 
0.17 ±  0.03  4.21 ±  0.9  5.7 ±  1.1  2.76 ±  0.08  0.71 ±  0.03  3.22 ±  0.7 
0.5% group rats  0.18 ±  0.05  4.42 ±  1.0  6.34 ±  1.1  2.77 ±  0.09  0.718 ±  0.037  3.20 ±  0.8 
0% group rats  1 
month 
0.241 ±  0.05  6.57 ±  1.0  8.28 ±  1.54  3.34 ±  0.67  1.86 ±  0.36  5.33 ±  1.64 
0.5% group rats  0.267 ±  0.03  6.82 ±  0.88  8.41 ±  1.33  3.54 ±  0.78  1.99 ±  0.34  5.35 ±  1.55 
0% group rats  2 
months 
0.38 ±  0.09  7.56 ±  1.82  10.87 ±  3.1  4.01 ±  1.64  3.75 ±  1.22  7.16 ±  2.31 
0.5% group rats  0.43 ±  0.07 *  8.41 ±  1.34 *  13.88 ±  2.87 *  5.17 ±  1.77 *  4.8 ±  1.12 *  8.13 ±  2.13 * 
2.7. Affinity of Pseudopurpurin and Calcium 
The chemical reaction of pseudopurpurin and calcium was complete, in each test tube the remaining 
calcium content was measured by chemical analyzers. Figure 5 shows the remaining calcium contents 
were lowest  at a concentration of 0.5% pseudopurpurin, and then the remaining calcium contents 
began to rise with the increase of pseudopurpurin concentration in vitro. This demonstrated that the 
affinity of 0.5% pseudopurpurin and calcium ion is at its strongest compared with other concentrations 
of pseudo-purpurin in vitro. Int. J. Mol. Sci. 2012, 13 
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Figure 5. Each test tube showing residual calcium contents depending on the different dose 
of pseudopurpurin in vitro. Data are expressed as the means ±  SD.   
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2.8. Discussion   
It has been known for many years that the bones of animals are colored red by feeding on the roots 
of the Rubia tinctorum L., which contains a number of coloring agents. However, Richter found that 
madder contained considerable quantities of pseudopurpurin, and considered that pseudopurpurin was 
mainly responsible for the vital staining of the bones of animals fed on madder, and was completely 
non-toxic to animals [14]. In the present study we showed that the data for calcium affinity depends   
on the dose of pseudopurpurin, and these results further demonstrated that at 0.5% pseudopurpurin the 
affinity  of  calcium  ion  is  at  its  strongest  compared  to  other  concentrations  of  pseudopurpurin   
in vitro. Therefore, the rats were fed a new mixed pelleted diet in which 0.5% pseudopurpurin powder 
was  added.  Gross  and  microscopic  examination  of  the  kidney  and  liver  showed  that  there  was  no 
pathological alteration in the rats in the 0.5% group compared to those in the 0% group. Concurrently, 
the levels of biochemical indicator in the blood plasma of rats in the 0.5% group were similar to the 
0% group at 2 months after pseudopurpurin feeding. These results suggested that the administration of 
pseudopurpurin in the 0.5% group did not have significant toxic effects.   
Our  study  is  the  first  to  demonstrate  the  beneficial  effects  of  pseudopurpurin  extract  against 
reduction of bone mass and bone geometry architecture during growth and development of bone in rats. 
Bone is a very dynamic tissue which is constantly being repaired and renewed throughout life by the 
process  of  bone  remodeling.  The  organic  component  of  bone  forms  a  framework  upon  which 
mineralization occurs. Bone mineral is composed mainly of calcium and phosphate, laid down in the 
form of hydroxyapatite [Ca10(PO4)6(OH2)] crystals [16]. In this study, Ca, Mg and Zn levels in the   
rats  femur in  the group 0.5% were significantly increased compared  to  those in  the group 0% at   
1  and  2  months  after  pseudopurpurin  feeding.  A  rather  complicated  structural  formula  of  the 
calcium-aluminum-alizarin  compound  was  suggested  by  Rutishauser  in  1940  [17].  Kiel  and   
Heertjes [18–21] investigated the composition and structure of compounds formed by alizarin and its 
3-derivatives with calcium, aluminum and various other metals. Pseudopurpurin resembles alizarin 
because it forms a colored metal salt that is highly insoluble in water [14]. Therefore, it is worth 
considering that the increasing deposition of principal salts in red bone is possibly associated with 
pseudopurpurin,  which  has  a  selective  affinity  for  the  principal  salts  of  bone.  Minerals  formed   
in vitro have been found to consist of calcium and phosphorus deposited on well-banded collagen Int. J. Mol. Sci. 2012, 13 
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fibrils, with some of the crystals matured further into hydroxyapatite crystals [22,23]. Pseudopurpurin 
has a selective affinity for the principal salts of bone, and the pseudopurpurin-calcium salt, comes into 
contact  with  osteoid-tissue  and  the  organic  component  of  developing  bone  [14].  The 
pseudopurpurin-calcium salt has an adhesiveness which results in the calcium ion not being lost in 
bone metabolism. Calcium (Ca) is the major hydroxyapatite in bones [24]. Magnesium (Mg) is the 
second  most  abundant  intracellular  cation  in  vertebrates  [25].  Magnesium  can  promote  normal 
hydroxyapatite crystal growth [26]. In addition, trace elements are important in bone metabolism, as 
zinc  and  magnesium  are  closely  bound  to  apatite  crystals  and  zinc  is  essential  for  the  alkaline 
phosphates in osteoblasts [27]. Zinc is bound to hydroxyapatite and mobilizes slowly during bone 
remodeling [28–31]. Therefore, pseudopurpurin increases bone mineral density (BMD) due to the high 
level of major mineral elements and trace elements present in the bone of rats [32].   
BMD is the gold standard for evaluation of individuals at risk of osteoporosis, as it best predicts the 
fracture risk in people without previous fractures [33]. In the current study, the results manifested that 
BMD in the femur in the group 0.5% was significantly increased compared to that in the groups 0%. 
Measuring such microarchitectural parameters as the percent bone volume, trabecular bone structure, 
trabecular thickness, and trabecular separation may improve our ability to estimate bone strength [34–38]. 
In this study, the effects of a 0.5% dose of pseudopurpurin in the diet on femoral microarchitecture 
were investigated by scanning with micro-CT. The results of the micro-CT evaluation demonstrated 
that there were differences in all of the parameters of the femur among rats in the 0% and 0.5% groups 
at 2 months after pseudopurpurin feeding. 
At one month after pseudopurpurin feeding, BV/TV, Tb.Th and Tb.N were significantly increased 
and Tb.Sp and SMI were significantly decreased in the distal femur in the 0.5% group compared with 
those  in  the  0%  group.  At  two  months  after  pseudopurpurin  feeding,  the  mean  thickness,  outer 
perimeter, cortical area, total area, inner perimeter and marrow area in the femur diaphysis, as well as 
BV/TV, Tb.Th and Tb.N in the distal femur in the 0.5% group were significantly increased and Tb.Sp 
and SMI were significantly decreased compared with the 0% group. SMI of 0 and 3 represent bones 
that consist purely of plate- or rod-like structures, respectively [39]. The above results indicate that an 
increase of BMD and bone geometry architecture in the 0.5% group is related to the enhancement of 
the deposition of principal salts in red bone, which is possibly associated with a selective affinity of 
pseudopurpurin for the principal salts of bone. This suggests an adhesiveness of the calcium-dyestuff 
salts  on  the  bone  collagenous  matrix  so  that  not  many  calcium  ions  are  lost  during  metabolism, 
promoting calcium salt mineralization deposition, and leading to enhanced structure and strength of 
bone. The overall quality of bone is determined by such characteristics as microarchitecture, geometry 
and material properties, all of which are affected by the rate of bone turnover [40]. 
3. Materials and Methods 
3.1. Preparation of Pseudopurpurin 
Commercially available madder powder was obtained from the Chinese Herbal Medicine Company 
(Kunming, Yunnan province, China). The dried madder root, dispersed in a mixture of 200 μL 1 mol· L
−1 
HCl solution and 200 μL methanol, was heated at 60 ° C for 15 min with agitation. After addition of   Int. J. Mol. Sci. 2012, 13 
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10 mL water, the anthraquinones were extracted with 2 mL ethyl acetate. After a separation step and 
removal of the aqueous phase, evaporation of the solvent was performed under argon. The dry extract 
was then dissolved in 40 μL methanol before being injected on to the HPLC column. 
3.2. Semi-Preparative HPLC   
The impurities of pseudopurpurin were isolated using a Waters auto-purification system equipped 
with a 2525 binary gradient pump, a 2487 UV detector and a 2767 sample manager (Waters, Milford, 
MA, USA). A Water SunFire™ prep C 18 OBD™ column (150 mm ×  30 mm i.d., particle size 10 μm) 
was  used  for  semi-preparative  isolation.  Gradient  elution  was  performed  using  a  20  mmol· L
−1 
ammonium acetate solution in water as mobile phase A and methanol as mobile phase B. The gradient 
composition was set from 0 to 95% B over 25 min and then to 100% B over 5 min; the 100% value 
was held for 20 min. The flow rate was set to 1 mL· min
−1 and the injection volume was 1 mL. The 
column  temperature  was  30  °C   and  the  detection  wavelength  was  255  nm.  The  sample  solutions 
(~100 mg/mL) were prepared in the mobile phase. 
3.3. Electrospray Ionization-Mass Spectrometry (ESI-MS) 
An LTQXL system (Thermo, USA) with ESI ion source in the negative ion mode was used for 
qualitative analysis of the compounds. The separation was performed on an ACUITY UPLC
® BEH 
C18 column (1.7 μm, 50 mm ×  3 mm i.d., Waters, USA). The linear gradient conditions were the same 
as those used for UPLC-UV analysis. Elution was performed at a solvent flow rate of 0.4 mL/min, and 
a  portion  of  the  column  effluent  (0.2  mL/min)  was  delivered  into  the  ion  source  of  the  mass 
spectrometer. The conditions of MS analysis were as follows: Sheat Gas Flow Rate: 40, AUX Gas 
Flow Rate: 5, Sweep Gas Flow Rate: 1, Spray voltage (kv): 4; Capillary Temp (°C ): 250, Capillary 
Voltage (V): 22.0, Tube Lens: 100. 
3.4. Animals 
All 1-month old female Wistar rats were acquired from the Experimental Animal Center in the First 
Clinical  Hospital  of  Jilin  University.  All  rats  were  fed  in  high  efficiency  particulate  air 
(HEPA)-filtered isolation units at a constant 25 ° C. Local government and the Medical Science Animal 
Experiment Committee of Jilin University agreed to use these rats for experiments. All rats in the the 
group 0% (n = 20), and the group 0.5% (n = 20) were used for this study, and were fed pelleted diets 
which 0% pseudopurpurin powder (group 0%) and 0.5% pseudopurpurin powder (group 0.5%) was 
added, and the group 0% was used as a control. Two group rats were fed a commercially available 
pelleted diet as prescribed by the manufacturer to fulfill all dietary needs. Rats in each group were 
sacrificed in batches at 0.5, 1 and 2 months after pseudopurpurin feeding by an overdose of sodium 
pentobarbital intraperitoneally and then their left femur were removed. At necropsy, the whole left 
femurs were first used for Dual energy X-ray absorptiometry (DEXA). The left femur diaphysis and 
the distal femur (n = 10, group 0.5%; n = 10, group 0%) were used prior to submission for micro-CT 
analysis. The left femurs (n = 10, group 0.5%; n = 10, group 0%) were used for an inductively coupled 
plasma optical emission spectrometer. Body weight and femur length were recorded. Int. J. Mol. Sci. 2012, 13 
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3.5. Bone Mineral Elements 
In all groups, the left femur samples from each rat were first cut into pieces with a ceramic knife to 
avoid metal contamination, and then the pieces obtained were dried under vacuum at 50 °C  to remove 
water  and  some  volatile  organic  components.  Samples  after  pretreatment  were  weighed  (0.5 g) 
precisely into 30 mL vessels and 5 mL of high purity HNO3 was added. The vessels were then placed 
on a heating furnace with the temperature set at 120 °C  until clean solutions were obtained. After 
cooling, the solutions were transferred into 25 mL flasks and fixed to volume with ultrapure water. An 
inductively coupled plasma optical emission spectrometer (ICP-OES, iCAP6300, ThermoScientific, 
USA) was employed for analysis of major elements.   
3.6. Dual Energy X-ray Absorptiometry 
All left femurs were assessed for Dual energy X-ray Absorptiometry (DEXA). Prior to testing, they 
were slowly brought to room temperature in a saline bath. Scanning was performed with each bone 
positioned on its caudal surface, and bone mineral density (BMD; mg/cc) was collected from femur 
diaphysis of all rats. 
3.7. Histopathological Analysis 
Kidneys, livers, hearts, spleens, stomachs and lungs samples were harvested from rats in all groups 
at 2 months after treatment, and were fixed in 10% neutral buffered formalin and embedded in paraffin 
for histopathological analysis. The tissue samples were sectioned at 4 μm. Cross-sectioned tissues were 
stained with hematoxylin and eosin. The following tissues were examined by light microscopy for the 
presence of lesions. 
3.8. Detection of Blood of Rats 
The  blood  samples  containing  anticoagulant  heparin  sodium  were  used  for  the  detection.  The 
separated  plasma  from  the  remaining  blood  was  used  for  the  detection  of  the  aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and creatinine 
(CRE)  using  the  Beckman  Synchron  CX7  Delta  Chemistry  Analyzers  (Beckman,  USA).  Each 
detection was performed in triplicate. 
3.9. Micro-CT Scanning 
After euthanasia, the left femurs of all rats were scanned by a desktop micro-CT system (eXplore 
Locus SP, GE Healthcare, USA). For image acquisition, the specimens were incised into cylinders   
20  mm  in  diameter.  The  specimens  were  scanned  with  14  μm  isotropic  voxel  size  using  a  large   
tube-14  μm-150  min-ss-micro-tomography  scan  protocol.  The  scan  protocol  consisted  of  rotation 
through 210°  at a rotation step of 0.4° , X-ray settings were standardized to 80 kV and 80 μA, and the 
exposure  time  was  2960  ms  per  frame.  The  scan  time  was  approximately  150  min  per  sample. 
Three-dimensional  (3-D)  surface  renderings  were  performed  using  Mic-view  V  2.1.2  3-D 
reconstruction software. Regions of interest (ROIs) were reconstructed and analyzed by micro-CT with Int. J. Mol. Sci. 2012, 13 
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the same thresholds. The database was analyzed, which led to 3-D parameters of each ROI. Each pair 
of these parameters in the same specimen was compared for each group. 
3.10. Affinity of Pseudopurpurin and Calcium Test 
The  red  calcium  salt  of  pseudopurpurin  floated  on  water  and  was  formed  in  neutral  solution.   
To investigate the affinity of pseudopurpurin and calcium ions, to each test tube was added 10 mL   
10 mM CaCl2 (pH 7.0) and 1 mL different dose of pseudopurpurin. The doses of pseudopurpurin were 
0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1%, respectively. These samples were homogenized and 
centrifuged (5000 g) for 15 min at 4 ° C. The upper solid phase of the calcium salt of pseudopurpurin 
was removed, and the lower aqueous phase with remains of the calcium ions was measured by the 
Beckman Synchron CX7 Delta Chemistry Analyzers (Beckman, USA). Each detection was performed 
in triplicate. 
3.11. Statistical Analyses 
All  data  are  expressed  as  mean  values  ±   S.D.  Data  were  considered  statistically  significant  at   
P < 0.05 using paired t-test. All statistical analyses were performed using the statistical package SPSS 
for Windows version 11. 
4. Conclusions 
According to the above results, we consider that adding pseudopurpurin to the diet of rats at a 
concentration  of  0.5%  is  most  suitable.  The  feeding  of  0.5%  pseudopurpurin  which  has  specific 
chemical affinities for calcium for bone improvement and level of bone mineral density enhances the 
geometry architecture compared with the 0% group. 
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